HomeARDS • OTCMKTS
add
Aridis Pharmaceuticals Inc
Previous close
$0.0023
Day range
$0.00020 - $0.0023
Market cap
9.64K USD
Avg Volume
16.02K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | 2022info | Y/Y change |
|---|---|---|
Revenue | 3.09M | 101.37% |
Operating expense | 7.16M | -2.04% |
Net income | -30.37M | 28.02% |
Net profit margin | -982.56 | 64.25% |
Earnings per share | — | — |
EBITDA | -29.28M | 30.74% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | 2022info | Y/Y change |
|---|---|---|
Cash and short-term investments | 4.88M | -73.06% |
Total assets | 14.70M | -45.16% |
Total liabilities | 38.93M | -2.45% |
Total equity | -24.23M | — |
Shares outstanding | 36.08M | — |
Price to book | -0.00 | — |
Return on assets | -89.68% | — |
Return on capital | 147.45% | — |
Cash Flow
Net change in cash
| (USD) | 2022info | Y/Y change |
|---|---|---|
Net income | -30.37M | 28.02% |
Cash from operations | -29.13M | -26.99% |
Cash from investing | -82.00K | 84.53% |
Cash from financing | 14.78M | -57.43% |
Net change in cash | -14.43M | -228.19% |
Free cash flow | -17.85M | -14.93% |
About
Founded
2003
Headquarters
Website
Employees
37
